Lymphokine-activated killer cell (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lymphokine-activated killer cell" in English language version.

refsWebsite

Global rank English rank

19nih.gov

4^th place

11doi.org

2^nd place

6worldcat.org

5^th place

1oup.com

485^th place

440^th place

1iiarjournals.org

low place

1wiley.com

222^nd place

297^th place

doi.org (Global: 2^nd place; English: 2^nd place)

West, E. J.; Scott, K. J.; Jennings, V. A.; Melcher, A. A. (2011). "Immune activation by combination human lymphokine-activated killer and dendritic cell therapy". British Journal of Cancer. 105 (6): 787–795. doi:10.1038/bjc.2011.290. ISSN 1532-1827. PMC 3171008. PMID 21847125.
Shau, Hungyi; Kim, Anthony; Golub, Sidney H (1992-04-01). "Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin". Journal of Leukocyte Biology. 51 (4): 343–349. doi:10.1002/jlb.51.4.343. ISSN 0741-5400. PMID 1564398.
Grimm, E. A.; Mazumder, A.; Zhang, H. Z.; Rosenberg, S. A. (1982-06-01). "Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes". The Journal of Experimental Medicine. 155 (6): 1823–1841. doi:10.1084/jem.155.6.1823. ISSN 0022-1007. PMC 2186695. PMID 6176669.
West EJ, Scott KJ, Jennings VA, Melcher AA (September 2011). "Immune activation by combination human lymphokine-activated killer and dendritic cell therapy". Br J Cancer. 105 (6): 787–95. doi:10.1038/bjc.2011.290. PMC 3171008. PMID 21847125.
Ganina, Anastasia; Askarov, Manarbek; Kozina, Larissa; Karimova, Madina; Shayakhmetov, Yerzhan; Mukhamedzhanova, Perizat; Brimova, Aigul; Berikbol, Daulet; Chuvakova, Elmira; Zaripova, Lina; Baigenzhin, Abay (2024-12-06). "Prospects for Treatment of Lung Cancer Using Activated Lymphocytes Combined with Other Anti-Cancer Modalities". Advances in Respiratory Medicine. 92 (6): 504–525. doi:10.3390/arm92060045. ISSN 2543-6031. PMC 11673795. PMID 39727496.
Zhao, Shuang; Cui, Jinling; Cao, Lixing; Han, Kai; Ma, Xuan; Chen, Hui; Yin, Shutao; Zhao, Chong; Ma, Changwei; Hu, Hongbo (2023). "Xanthohumol inhibits non-small cell lung cancer via directly targeting T-lymphokine-activated killer cell-originated protein kinase". Phytotherapy Research. 37 (7): 3057–3068. doi:10.1002/ptr.7799. ISSN 1099-1573.
Rosenberg SA (June 2014). "IL-2: the first effective immunotherapy for human cancer". J Immunol. 192 (12): 5451–8. doi:10.4049/jimmunol.1490019. PMC 6293462. PMID 24907378.
Maeta N, Tamura K, Takemitsu H, Miyabe M (July 2019). "Lymphokine-activated killer cell transplantation after anti-cancer treatment in two aged cats". Open Vet J. 9 (2): 147–150. doi:10.4314/ovj.v9i2.9. PMC 6626148. PMID 31360654.
Jennings VA, Ilett EJ, Scott KJ, West EJ, Vile R, Pandha H, Harrington K, Young A, Hall GD, Coffey M, Selby P, Errington-Mais F, Melcher AA (March 2014). "Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites". Int J Cancer. 134 (5): 1091–101. doi:10.1002/ijc.28450. PMC 4321045. PMID 23982804.
Haustein M, Ramer R, Linnebacher M, Manda K, Hinz B (November 2014). "Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1". Biochem Pharmacol. 92 (2): 312–25. doi:10.1016/j.bcp.2014.07.014. PMID 25069049.
Rosenberg SA, Lotze MT, Yang JC, Aebersold PM, Linehan WM, Seipp CA, White DE (October 1989). "Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients". Ann Surg. 210 (4): 474–84, discussion 484–5. doi:10.1097/00000658-198910000-00008. PMC 1357927. PMID 2679456.

iiarjournals.org (Global: low place; English: low place)

ar.iiarjournals.org

Saito, Hiroki; Ando, Satoshi; Morishita, Naoya; Lee, Kyung-Mi; Dator, Dante; Dy, David; Shigemura, Katsumi; Adhim, Zainal; Nibu, Ken-Ichi; Fujisawa, Masato; Shirakawa, Toshiro (2014-07-01). "A Combined Lymphokine-activated Killer (LAK) Cell Immunotherapy and Adenovirus-p53 Gene Therapy for Head and Neck Squamous Cell Carcinoma". Anticancer Research. 34 (7): 3365–3370. ISSN 0250-7005. PMID 24982341.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

West, E. J.; Scott, K. J.; Jennings, V. A.; Melcher, A. A. (2011). "Immune activation by combination human lymphokine-activated killer and dendritic cell therapy". British Journal of Cancer. 105 (6): 787–795. doi:10.1038/bjc.2011.290. ISSN 1532-1827. PMC 3171008. PMID 21847125.
Shau, Hungyi; Kim, Anthony; Golub, Sidney H (1992-04-01). "Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin". Journal of Leukocyte Biology. 51 (4): 343–349. doi:10.1002/jlb.51.4.343. ISSN 0741-5400. PMID 1564398.
Grimm, E. A.; Mazumder, A.; Zhang, H. Z.; Rosenberg, S. A. (1982-06-01). "Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes". The Journal of Experimental Medicine. 155 (6): 1823–1841. doi:10.1084/jem.155.6.1823. ISSN 0022-1007. PMC 2186695. PMID 6176669.
West EJ, Scott KJ, Jennings VA, Melcher AA (September 2011). "Immune activation by combination human lymphokine-activated killer and dendritic cell therapy". Br J Cancer. 105 (6): 787–95. doi:10.1038/bjc.2011.290. PMC 3171008. PMID 21847125.
Ganina, Anastasia; Askarov, Manarbek; Kozina, Larissa; Karimova, Madina; Shayakhmetov, Yerzhan; Mukhamedzhanova, Perizat; Brimova, Aigul; Berikbol, Daulet; Chuvakova, Elmira; Zaripova, Lina; Baigenzhin, Abay (2024-12-06). "Prospects for Treatment of Lung Cancer Using Activated Lymphocytes Combined with Other Anti-Cancer Modalities". Advances in Respiratory Medicine. 92 (6): 504–525. doi:10.3390/arm92060045. ISSN 2543-6031. PMC 11673795. PMID 39727496.
Saito, Hiroki; Ando, Satoshi; Morishita, Naoya; Lee, Kyung-Mi; Dator, Dante; Dy, David; Shigemura, Katsumi; Adhim, Zainal; Nibu, Ken-Ichi; Fujisawa, Masato; Shirakawa, Toshiro (2014-07-01). "A Combined Lymphokine-activated Killer (LAK) Cell Immunotherapy and Adenovirus-p53 Gene Therapy for Head and Neck Squamous Cell Carcinoma". Anticancer Research. 34 (7): 3365–3370. ISSN 0250-7005. PMID 24982341.
Rosenberg SA (June 2014). "IL-2: the first effective immunotherapy for human cancer". J Immunol. 192 (12): 5451–8. doi:10.4049/jimmunol.1490019. PMC 6293462. PMID 24907378.
Maeta N, Tamura K, Takemitsu H, Miyabe M (July 2019). "Lymphokine-activated killer cell transplantation after anti-cancer treatment in two aged cats". Open Vet J. 9 (2): 147–150. doi:10.4314/ovj.v9i2.9. PMC 6626148. PMID 31360654.
Jennings VA, Ilett EJ, Scott KJ, West EJ, Vile R, Pandha H, Harrington K, Young A, Hall GD, Coffey M, Selby P, Errington-Mais F, Melcher AA (March 2014). "Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites". Int J Cancer. 134 (5): 1091–101. doi:10.1002/ijc.28450. PMC 4321045. PMID 23982804.
Haustein M, Ramer R, Linnebacher M, Manda K, Hinz B (November 2014). "Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1". Biochem Pharmacol. 92 (2): 312–25. doi:10.1016/j.bcp.2014.07.014. PMID 25069049.
Rosenberg SA, Lotze MT, Yang JC, Aebersold PM, Linehan WM, Seipp CA, White DE (October 1989). "Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients". Ann Surg. 210 (4): 474–84, discussion 484–5. doi:10.1097/00000658-198910000-00008. PMC 1357927. PMID 2679456.

ncbi.nlm.nih.gov

West, E. J.; Scott, K. J.; Jennings, V. A.; Melcher, A. A. (2011). "Immune activation by combination human lymphokine-activated killer and dendritic cell therapy". British Journal of Cancer. 105 (6): 787–795. doi:10.1038/bjc.2011.290. ISSN 1532-1827. PMC 3171008. PMID 21847125.
Grimm, E. A.; Mazumder, A.; Zhang, H. Z.; Rosenberg, S. A. (1982-06-01). "Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes". The Journal of Experimental Medicine. 155 (6): 1823–1841. doi:10.1084/jem.155.6.1823. ISSN 0022-1007. PMC 2186695. PMID 6176669.
West EJ, Scott KJ, Jennings VA, Melcher AA (September 2011). "Immune activation by combination human lymphokine-activated killer and dendritic cell therapy". Br J Cancer. 105 (6): 787–95. doi:10.1038/bjc.2011.290. PMC 3171008. PMID 21847125.
Ganina, Anastasia; Askarov, Manarbek; Kozina, Larissa; Karimova, Madina; Shayakhmetov, Yerzhan; Mukhamedzhanova, Perizat; Brimova, Aigul; Berikbol, Daulet; Chuvakova, Elmira; Zaripova, Lina; Baigenzhin, Abay (2024-12-06). "Prospects for Treatment of Lung Cancer Using Activated Lymphocytes Combined with Other Anti-Cancer Modalities". Advances in Respiratory Medicine. 92 (6): 504–525. doi:10.3390/arm92060045. ISSN 2543-6031. PMC 11673795. PMID 39727496.
Rosenberg SA (June 2014). "IL-2: the first effective immunotherapy for human cancer". J Immunol. 192 (12): 5451–8. doi:10.4049/jimmunol.1490019. PMC 6293462. PMID 24907378.
Maeta N, Tamura K, Takemitsu H, Miyabe M (July 2019). "Lymphokine-activated killer cell transplantation after anti-cancer treatment in two aged cats". Open Vet J. 9 (2): 147–150. doi:10.4314/ovj.v9i2.9. PMC 6626148. PMID 31360654.
Jennings VA, Ilett EJ, Scott KJ, West EJ, Vile R, Pandha H, Harrington K, Young A, Hall GD, Coffey M, Selby P, Errington-Mais F, Melcher AA (March 2014). "Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites". Int J Cancer. 134 (5): 1091–101. doi:10.1002/ijc.28450. PMC 4321045. PMID 23982804.
Rosenberg SA, Lotze MT, Yang JC, Aebersold PM, Linehan WM, Seipp CA, White DE (October 1989). "Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients". Ann Surg. 210 (4): 474–84, discussion 484–5. doi:10.1097/00000658-198910000-00008. PMC 1357927. PMID 2679456.

oup.com (Global: 485^th place; English: 440^th place)

academic.oup.com

Shau, Hungyi; Kim, Anthony; Golub, Sidney H (1992-04-01). "Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin". Journal of Leukocyte Biology. 51 (4): 343–349. doi:10.1002/jlb.51.4.343. ISSN 0741-5400. PMID 1564398.

wiley.com (Global: 222^nd place; English: 297^th place)

onlinelibrary.wiley.com

Zhao, Shuang; Cui, Jinling; Cao, Lixing; Han, Kai; Ma, Xuan; Chen, Hui; Yin, Shutao; Zhao, Chong; Ma, Changwei; Hu, Hongbo (2023). "Xanthohumol inhibits non-small cell lung cancer via directly targeting T-lymphokine-activated killer cell-originated protein kinase". Phytotherapy Research. 37 (7): 3057–3068. doi:10.1002/ptr.7799. ISSN 1099-1573.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

West, E. J.; Scott, K. J.; Jennings, V. A.; Melcher, A. A. (2011). "Immune activation by combination human lymphokine-activated killer and dendritic cell therapy". British Journal of Cancer. 105 (6): 787–795. doi:10.1038/bjc.2011.290. ISSN 1532-1827. PMC 3171008. PMID 21847125.
Shau, Hungyi; Kim, Anthony; Golub, Sidney H (1992-04-01). "Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin". Journal of Leukocyte Biology. 51 (4): 343–349. doi:10.1002/jlb.51.4.343. ISSN 0741-5400. PMID 1564398.
Grimm, E. A.; Mazumder, A.; Zhang, H. Z.; Rosenberg, S. A. (1982-06-01). "Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes". The Journal of Experimental Medicine. 155 (6): 1823–1841. doi:10.1084/jem.155.6.1823. ISSN 0022-1007. PMC 2186695. PMID 6176669.
Ganina, Anastasia; Askarov, Manarbek; Kozina, Larissa; Karimova, Madina; Shayakhmetov, Yerzhan; Mukhamedzhanova, Perizat; Brimova, Aigul; Berikbol, Daulet; Chuvakova, Elmira; Zaripova, Lina; Baigenzhin, Abay (2024-12-06). "Prospects for Treatment of Lung Cancer Using Activated Lymphocytes Combined with Other Anti-Cancer Modalities". Advances in Respiratory Medicine. 92 (6): 504–525. doi:10.3390/arm92060045. ISSN 2543-6031. PMC 11673795. PMID 39727496.
Saito, Hiroki; Ando, Satoshi; Morishita, Naoya; Lee, Kyung-Mi; Dator, Dante; Dy, David; Shigemura, Katsumi; Adhim, Zainal; Nibu, Ken-Ichi; Fujisawa, Masato; Shirakawa, Toshiro (2014-07-01). "A Combined Lymphokine-activated Killer (LAK) Cell Immunotherapy and Adenovirus-p53 Gene Therapy for Head and Neck Squamous Cell Carcinoma". Anticancer Research. 34 (7): 3365–3370. ISSN 0250-7005. PMID 24982341.
Zhao, Shuang; Cui, Jinling; Cao, Lixing; Han, Kai; Ma, Xuan; Chen, Hui; Yin, Shutao; Zhao, Chong; Ma, Changwei; Hu, Hongbo (2023). "Xanthohumol inhibits non-small cell lung cancer via directly targeting T-lymphokine-activated killer cell-originated protein kinase". Phytotherapy Research. 37 (7): 3057–3068. doi:10.1002/ptr.7799. ISSN 1099-1573.